Opening Hours : Saturday to Saturday - 9am to 6pm | Email: info@cancercarespecialtiesmena.com

EMAIL

info@cancercarespecialtiesmena.com

Call Now

+971569534772 Dubai and Sharjah
+971507885001 Abu Dhabi and Al Ain

Group of Recent Papers | Cancer Care Center UAE

18 Sep
0

Metachronous Bilateral Extremity Soft Tissue Sarcomas

Colon cancer is cancer of the large intestine (colon), the lower part of your digestive system. Rectal cancer is cancer of the last several inches of the colon. Together, they’re often referred to as colorectal cancers. Our consultant surgeonsare skilled in colon and rectal surgery using advanced surgical techniques to remove cancer, such as minimally

14 Jul
0

Molecular spectrum of KRAS, NRAS, BRAF, PIK3CA, TP53, and APC somatic gene mutations in Arab patients with colorectal cancer: determination of frequency and distribution pattern

Molecular spectrum of KRAS, NRAS, BRAF, PIK3CA, TP53, and APC somatic gene mutations in Arab patients with colorectal cancer: determination of frequency and distribution pattern Colorectal surgery  Dubai UAE Sadir Alrawi MD FRCSEd FRCSEng CABS DGS , Best Oncology Team for ColoRectal Surgery, Head & Neck Surgery, Liver & Pancreas Surgery, Melanoma & Sarcoma, HIPEC,

18 May
0

Capecitabine-induced leukocytoclastic vasculitis under neoadjuvant chemotherapy for locally advanced colorectal cancer

Humaid O. Al-Shamsi1, Bryan K. Kee1, Michael T. Tetzlaff2, Robert A. Wolff1 Department of Gastrointestinal Medical Oncology, Department of Pathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, TX 77030, USA Correspondence to: Humaid O. Al-Shamsi. Assistant Professor, Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson

13 Feb
0

Thrombotic events in metastatic colorectal cancer patients treated with leucovorin, fluorouracil and irinotican (FOLFIRI) plus bevacizumab

Thrombotic events in metastatic colorectal cancer patients treated with leucovorin, fluorouracil and irinotican (FOLFIRI) plus bevacizumab Humaid O. Al-Shamsi1,2,3, Abdulaziz Al Farsi1, Mahraz Anjum2, Hua Shen2, Kevin Zbuk1, Richard J. Cook2, Lori-Ann Linkins4, Pierre Major1 1Department of Oncology, McMaster University, Hamilton, Ontario, Canada; 2Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, Ontario, Canada;

17 Sep
0

A multicentre analysis of abiraterone acetate in Canadian patients with metastatic castration-resistant prostate cancer

A multicentre analysis of abiraterone acetate in Canadian patients with metastatic castration-resistant prostate cancer

18 Jul
0

Stage III NoneSmall-Cell Lung Cancer: Establishing a Benchmark for the Proportion of Patients Suitable for Radical Treatment

Stage III NoneSmall-Cell Lung Cancer: Establishing a Benchmark for the Proportion of Patients Suitable for Radical Treatment

18 Sep
0

The Current Practice of Screening, Prevention, and Treatment of Androgen-Deprivation-Therapy Induced Osteoporosis in Patients with Prostate Cancer

The Current Practice of Screening, Prevention, and Treatment of Androgen-Deprivation-Therapy Induced Osteoporosis in Patients with Prostate Cancer